NCT00170976View on ClinicalTrials.gov

A Year Long Study to Evaluate the Safety of the Combination of Valsartan (320 mg) and Amlodipine (5 mg) in Patients With Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

403

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
HYPERTENSION
Interventions
DRUG

valsartan + amlodipine

Trial Locations (2)

Unknown

Sites in germany, Multiple Locations

Novartis Pharmaceuticals, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY